Mutational analysis of cis-acting packaging signals in human immunodeficiency virus type 1 RNA.
AUTOR(ES)
Luban, J
RESUMO
We previously identified blocks of sequence near the 5' end of the human immunodeficiency virus (HIV-1) genome which conferred on RNA the ability to bind specifically to the HIV-1 Gag polyprotein, Pr55gag (J. Luban and S. P. Goff, J. Virol. 65:3203-3212, 1991; R. Berkowitz, J. Luban, and S. P. Goff, J. Virol. 67:7190-7200, 1993). Here we report the use of an RNase protection assay to quantify the effect of deletion of these sequences on RNA packaging into virions. First, we demonstrated with wild-type HIV-1 sequences that in comparison with spliced viral RNA, full-length viral genomic RNA is enriched 20-fold in virions. A previously described mutation with deletion of sequences between the major splice donor and the first codon of gag (A. Lever, H. Gottlinger, W. Haseltine, and J. Sodroski, J. Virol. 63:4085-4087, 1989) disrupted these ratios such that different HIV-1 RNA forms were packaged in direct proportion to cytoplasmic concentrations. The effect of deletion mutations preceding and within gag coding sequence on packaging was then tested in competition with RNAs containing wild-type packaging sequences. Using this system, we were able to demonstrate significant effects on packaging of RNAs with mutations immediately preceding the first codon of gag. The greatest reduction in packaging was seen with RNAs lacking the first 40 nucleotides of gag coding sequence, although sequences more 3' had slight additional effects.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=236883Documentos Relacionados
- cis-acting sequences involved in human immunodeficiency virus type 1 RNA packaging.
- Packaging of human immunodeficiency virus type 1 RNA requires cis-acting sequences outside the 5' leader region.
- Comparative mutational analysis of cis-acting RNA signals for translational frameshifting in HIV-1 and HTLV-2
- Location of cis-acting signals important for RNA encapsidation in the leader sequence of human immunodeficiency virus type 2.
- Autoantigens interact with cis-acting elements of rubella virus RNA.